John Meredith Mount Jr.

CIK: 0001942414

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CHE

CHEMED CORP

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

CHE
CHEMED CORP
May 18, 2026
Award(A)
Direct
386 shares at avg. $440.77$170K
CHE
CHEMED CORP
May 19, 2025
Award(A)
Direct
277 shares at avg. $579.04$160K

		Type	Shares	Price		Ownership
May 18, 2026	CHE CHEMED CORP	Award(A)	386	$440.77	$170,137	Direct
May 19, 2025	CHE CHEMED CORP	Award(A)	277	$579.04	$160,394	Direct

1-2 of 2 transactions

About Mount John Meredith Jr.

Mount John Meredith Jr. (SEC CIK 0001942414) files insider reports with the SEC as Director of CHEMED CORP (CHE).

Signal8 holds 2 ownership filings by Mount John Meredith Jr., all Form 4s, filed between May 20, 2025 and May 19, 2026. Those filings report 2 transactions, from May 19, 2025 to May 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Mount John Meredith Jr.'s filings is in ATLANTA, GA.

Recent filings by Mount John Meredith Jr.

May 18, 2026: Grant or award of CHE shares (Form 4, code A).
May 19, 2025: Grant or award of CHE shares (Form 4, code A).

Other insiders filing for CHEMED CORP (CHE)

LEE SPENCER S, executive vice president
Wherley Joel L, CEO - Vitas Healthcare
Judkins Brian C, VP and Chief Legal Officer
HUTTON THOMAS C, vice president
Witzeman Michael D, VP & Chief Financial Officer
MCNAMARA KEVIN J, president and CEO

How to read Form 4 transaction codes